Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.01% is 519% above its 4-year average of -0.48%, near the high end of its 4-year range (-6.35%–3.79%).
Reported quarterly return on assets; no daily interpolation. Q3 FY2026 (2026-07-03): 1.43%.
RETURN ON ASSETS (ROA)
2.01%
RETURN ON ASSETS (ROA) AVG TTM
N/A
RETURN ON ASSETS (ROA) AVG 3Y
-2.16%
RETURN ON ASSETS (ROA) AVG 5Y
-0.48%
RETURN ON ASSETS (ROA) AVG 10Y
1.28%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+193.06%
CURRENT VS 5Y AVG
+518.75%
CURRENT VS 10Y AVG
+57.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+106.23%
vs the sector median at left
Varex Imaging Corporation
Market Cap
$778.01M
Return on Assets (ROA)
2.01%
TTM Avg
N/A
3Y Avg
-2.16%
5Y Avg
-0.48%
Market Cap
$777.34M
Return on Assets (ROA)
-24.44%
TTM Avg
-47.18%
3Y Avg
-56.01%
5Y Avg
-52.81%
Market Cap
$776.24M
Return on Assets (ROA)
-13.47%
TTM Avg
-22.22%
3Y Avg
-41.40%
5Y Avg
-40.82%
Market Cap
$785.03M
Return on Assets (ROA)
-5.26%
TTM Avg
0.19%
3Y Avg
-3.34%
5Y Avg
-3.22%
Market Cap
$789.34M
Return on Assets (ROA)
-8.70%
TTM Avg
6.33%
3Y Avg
-16.09%
5Y Avg
-46.82%
Market Cap
$765.30M
Return on Assets (ROA)
-49.09%
TTM Avg
-55.91%
3Y Avg
-48.67%
5Y Avg
-44.21%
Market Cap
$761.37M
Return on Assets (ROA)
1.14%
TTM Avg
0.56%
3Y Avg
-13.91%
5Y Avg
-9.14%
Market Cap
$753.02M
Return on Assets (ROA)
-36.55%
TTM Avg
-44.22%
3Y Avg
-44.22%
5Y Avg
-44.22%
Market Cap
$804.16M
Return on Assets (ROA)
10.76%
TTM Avg
17.66%
3Y Avg
20.82%
5Y Avg
23.86%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Varex Imaging Corporation (VREX) | $778.01M | 2.01% | N/A | -2.16% | -0.48% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -24.44% | -47.18% | -56.01% | -52.81% |
| Geron Corporation (GERN)vs › | $776.24M | -13.47% | -22.22% | -41.40% | -40.82% |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | -5.26% | 0.19% | -3.34% | -3.22% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | -8.70% | 6.33% | -16.09% | -46.82% |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | -49.09% | -55.91% | -48.67% | -44.21% |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 1.14% | 0.56% | -13.91% | -9.14% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | -36.55% | -44.22% | -44.22% | -44.22% |
| InMode Ltd. (INMD)vs › | $804.16M | 10.76% | 17.66% | 20.82% | 23.86% |
| Design Therapeutics, Inc. (DSGN)vs › | $747.61M | -32.91% | -25.26% | -23.04% | -20.66% |
ROA
2.0%
ROE
4.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-10-03 | -6.35% |
| 2024-09-27 | -3.92% |
| 2023-09-29 | 3.79% |
| 2022-09-30 | 2.56% |
| 2021-10-01 | 1.52% |
| 2020-10-02 | -5.08% |
| 2019-09-30 | 1.49% |
| 2018-09-30 | 2.78% |
| 2017-09-30 | 4.96% |
| 2016-09-30 | 11.01% |
| 2015-09-30 | 13.71% |
| 2014-09-30 | 25.42% |
| 2013-09-30 | 0.00% |
